...
首页> 外文期刊>Polyhedron: The International Journal for Inorganic and Organometallic Chemistry >Synthesis, characterization and biological activity of antimony(III) or bismuth(III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation
【24h】

Synthesis, characterization and biological activity of antimony(III) or bismuth(III) chloride complexes with dithiocarbamate ligands derived from thiuram degradation

机译:具有秋兰姆降解作用的二硫代氨基甲酸酯配体的氯化锑(III)或铋(III)配合物的合成,表征和生物学活性

获取原文
获取原文并翻译 | 示例
           

摘要

Antimony(III) or bismuth(III) complexes of formulae {[SbCl(Me _2DTC)_2]_n} (1), {[BiCl(Me_2DTC) _2]_n} (2) and {[Bi(Et2DTC)3] 2} (3) (Me_2DTCH = dimethyldithiocarbamate, C _3H_7NS_2 and Et2DTCH = diethyldithiocarbamate, C_5H_(11)NS_2) were isolated from the reactions between SbCl_3 or BiCl_3 with tetramethylthiuram monosulfide (Me4tms), tetramethylthiuram disulfide (Me4tds) or tetraethylthiuram disulfide (Et4tds). In the case of 1 two polymorphs were isolated depending on the synthetic procedure followed. Crystal growth from the reaction of antimony(III)-chloride with Me4tms in methanol produced 1a polymorph, while those derived from Me4tds in acetonitrile/dichloromethane produced 1b form. The complexes 1-3 were characterized by m.p., e.a., FT-IR, FT-Raman, ~1H, ~(13)C NMR spectroscopy and Thermal Gravimetry-Differential Thermal Analysis (TGA-DTA). Moreover, single crystal X-ray diffraction analysis was carried out for 1a, 1b, 2 and 3. X-ray powder diffraction data confirm the existence of one polymorph in the bulk of each sample of 1a and 1b. 1H NMR spectra in the DMSO-d_6 solutions of 1a and 1b suggest the retention of the structural variations. Complexes 1 and 2 are polymers with distorted square pyramidal (SPY) geometry in each monomeric unit. The known structure of 3 was re-determined to be used for the theoretical and structure activity relationship studies (SAR). Complexes 1-3 were evaluated for their in vitro cytotoxic activity against human breast adenocarcinoma (MCF-7) and human cervix adenocarcinoma (HeLa) cells. Complex 3 is more active against HeLa cells whereas 1a, 1b and 2 against MCF-7. Compound 1a shows slightly higher activity than 1b. Principal components analysis (PCA) was performed to discriminate the significant physicochemical molecular descriptors while regression analysis successfully related the experimental inhibitory concentration, (IC_(50))) to the independent variables indexed by PCA. The calculated IC50 values are satisfactorily compared with the measured inhibitory activity of the complexes.
机译:式{[SbCl(Me _2DTC)_2] _n}(1),{[BiCl(Me_2DTC)_2] _n}(2)和{[Bi(Et2DTC)3] 2]的锑(III)或铋(III)配合物}(3)从SbCl_3或BiCl_3与单硫化四甲基秋兰姆(Me4tms),二硫化四甲基秋兰姆(Me4tthramram)二硫化四甲基秋兰姆(Me4tms)或四甲基秋兰姆二硫化物(Me4tms)分离出(Me_2DTCH =二甲基二硫代氨基甲酸酯,C _3H_7NS_2和Et2DTCH =二乙基二硫代氨基甲酸,C_5H_(11)NS_2)。在1的情况下,根据随后的合成程序分离了两个多晶型物。氯化锑(III)与Me4tms在甲醇中反应生成的晶体产生1a多晶型,而Me4tds在乙腈/二氯甲烷中生成的晶体生成1b多晶型。配合物1-3的特征在于熔点,例如,FT-IR,FT-Raman,〜1H,〜(13)C NMR光谱和热重-差热分析(​​TGA-DTA)。此外,对1a,1b,2和3进行了单晶X射线衍射分析。X射线粉末衍射数据证实在1a和1b的每个样品的主体中存在一种多晶型物。 1a和1b的DMSO-d_6溶液中的1H NMR光谱表明保留了结构变异。配合物1和2是在每个单体单元中均具有扭曲的方形锥体(SPY)几何形状的聚合物。重新确定3的已知结构,以用于理论和结构活性关系研究(SAR)。评价复合物1-3对人乳腺腺癌(MCF-7)和人宫颈腺癌(HeLa)细胞的体外细胞毒性活性。复合物3对HeLa细胞更具活性,而1a,1b和2对MCF-7具有更高的活性。化合物1a的活性略高于1b。进行主成分分析(PCA)以区分重要的理化分子描述符,而回归分析成功地将实验抑制浓度(IC_(50))与PCA索引的自变量相关。将计算出的IC50值与测得的复合物抑制活性进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号